159 related articles for article (PubMed ID: 11676492)
1. Role of C-terminal region of HA-33 component of botulinum toxin in hemagglutination.
Sagane Y; Kouguchi H; Watanabe T; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2001 Nov; 288(3):650-7. PubMed ID: 11676492
[TBL] [Abstract][Full Text] [Related]
2. Molecular construction of Clostridium botulinum type C progenitor toxin and its gene organization.
Fujinaga Y; Inoue K; Shimazaki S; Tomochika K; Tsuzuki K; Fujii N; Watanabe T; Ohyama T; Takeshi K; Inoue K
Biochem Biophys Res Commun; 1994 Dec; 205(2):1291-8. PubMed ID: 7802661
[TBL] [Abstract][Full Text] [Related]
3. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
4. Sugar-binding sites of the HA1 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Tonozuka T; Ide A; Yuzawa T; Oguma K; Nishikawa A
J Mol Biol; 2008 Feb; 376(3):854-67. PubMed ID: 18178224
[TBL] [Abstract][Full Text] [Related]
5. Characterization and reconstitution of functional hemagglutinin of the Clostridium botulinum type C progenitor toxin.
Kouguchi H; Watanabe T; Sagane Y; Ohyama T
Eur J Biochem; 2001 Jul; 268(14):4019-26. PubMed ID: 11453996
[TBL] [Abstract][Full Text] [Related]
6. Four molecules of the 33 kDa haemagglutinin component of the Clostridium botulinum serotype C and D toxin complexes are required to aggregate erythrocytes.
Mutoh S; Suzuki T; Hasegawa K; Nakazawa Y; Kouguchi H; Sagane Y; Niwa K; Watanabe T; Ohyama T
Microbiology (Reading); 2005 Dec; 151(Pt 12):3847-3858. PubMed ID: 16339931
[TBL] [Abstract][Full Text] [Related]
7. Complete subunit structure of the Clostridium botulinum type D toxin complex via intermediate assembly with nontoxic components.
Mutoh S; Kouguchi H; Sagane Y; Suzuki T; Hasegawa K; Watanabe T; Ohyama T
Biochemistry; 2003 Sep; 42(37):10991-7. PubMed ID: 12974634
[TBL] [Abstract][Full Text] [Related]
8. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.
Fujinaga Y; Inoue K; Watarai S; Sakaguchi Y; Arimitsu H; Lee JC; Jin Y; Matsumura T; Kabumoto Y; Watanabe T; Ohyama T; Nishikawa A; Oguma K
Microbiology (Reading); 2004 May; 150(Pt 5):1529-1538. PubMed ID: 15133114
[TBL] [Abstract][Full Text] [Related]
9. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
[TBL] [Abstract][Full Text] [Related]
10. Characterization of sugar recognition by the toxin complex produced by the Clostridium botulinum serotype C variant strain Yoichi.
Matsuo T; Miyata K; Inui K; Ito H; Horiuchi R; Suzuki T; Yoneyama T; Oguma K; Niwa K; Watanabe T; Ohyama T
FEMS Immunol Med Microbiol; 2011 Oct; 63(1):35-43. PubMed ID: 21635567
[TBL] [Abstract][Full Text] [Related]
11. Quantitative detection of gene expression and toxin complex produced by Clostridium botulinum serotype D strain 4947.
Kouguchi H; Suzuki T; Hasegawa K; Mutoh S; Watanabe T; Niwa K; Yoneyama T; Katoh Y; Ohyama T
J Microbiol Methods; 2006 Dec; 67(3):416-23. PubMed ID: 16725219
[TBL] [Abstract][Full Text] [Related]
12. Conformational divergence in the HA-33/HA-17 trimer of serotype C and D botulinum toxin complex.
Sagane Y; Hayashi S; Akiyama T; Matsumoto T; Hasegawa K; Yamano A; Suzuki T; Niwa K; Watanabe T; Yajima S
Biochem Biophys Res Commun; 2016 Aug; 476(4):280-285. PubMed ID: 27237978
[TBL] [Abstract][Full Text] [Related]
13. Molecular composition of Clostridium botulinum type A progenitor toxins.
Inoue K; Fujinaga Y; Watanabe T; Ohyama T; Takeshi K; Moriishi K; Nakajima H; Inoue K; Oguma K
Infect Immun; 1996 May; 64(5):1589-94. PubMed ID: 8613365
[TBL] [Abstract][Full Text] [Related]
14. Identification of the interaction region between hemagglutinin components of the botulinum toxin complex.
Suzuki T; Miyashita S; Hayashi S; Miyata K; Inui K; Kondo Y; Miyazaki S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Int J Biol Macromol; 2014 Apr; 65():284-8. PubMed ID: 24472509
[TBL] [Abstract][Full Text] [Related]
15. Neurotoxin gene clusters in Clostridium botulinum type A strains: sequence comparison and evolutionary implications.
Dineen SS; Bradshaw M; Johnson EA
Curr Microbiol; 2003 May; 46(5):345-52. PubMed ID: 12732962
[TBL] [Abstract][Full Text] [Related]
16. Characterization of haemagglutinin activity of Clostridium botulinum type C and D 16S toxins, and one subcomponent of haemagglutinin (HA1).
Inoue K; Fujinaga Y; Honke K; Yokota K; Ikeda T; Ohyama T; Takeshi K; Watanabe T; Inoue K; Oguma K
Microbiology (Reading); 1999 Sep; 145 ( Pt 9)():2533-2542. PubMed ID: 10517606
[TBL] [Abstract][Full Text] [Related]
17. Spontaneous nicking in the nontoxic-nonhemagglutinin component of the Clostridium botulinum toxin complex.
Sagane Y; Watanabe T; Kouguchi H; Sunagawa H; Obata S; Oguma K; Ohyama T
Biochem Biophys Res Commun; 2002 Mar; 292(2):434-40. PubMed ID: 11906181
[TBL] [Abstract][Full Text] [Related]
18. Rho-specific Bacillus cereus ADP-ribosyltransferase C3cer cloning and characterization.
Wilde C; Vogelsgesang M; Aktories K
Biochemistry; 2003 Aug; 42(32):9694-702. PubMed ID: 12911311
[TBL] [Abstract][Full Text] [Related]
19. Mosaic type of the nontoxic-nonhemaggulutinin component gene in Clostridium botulinum type A strain isolated from infant botulism in Japan.
Kubota T; Shirakawa S; Kozaki S; Isogai E; Isogai H; Kimura K; Fujii N
Biochem Biophys Res Commun; 1996 Jul; 224(3):843-8. PubMed ID: 8713133
[TBL] [Abstract][Full Text] [Related]
20. Molecular composition of progenitor toxin produced by Clostridium botulinum type C strain 6813.
Watanabe T; Sagane Y; Kouguchi H; Sunagawa H; Inoue K; Fujinaga Y; Oguma K; Ohyama T
J Protein Chem; 1999 Oct; 18(7):753-60. PubMed ID: 10691185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
